Finance Home
-
My Yahoo
-
Yahoo!
-
Help
Saturday, December 26, 2009, 9:39PM ET - U.S. Markets Closed.
Dow
0.51%
Nasdaq
0.71%
Home
Investing
Market Overview
Market Stats
Stocks
Mutual Funds
ETFs
Bonds
Options
Industries
Currencies
New!
Education
News & Opinion
Markets
Investing Ideas
Expert Advice
Special Editions
Company Finances
Providers
Personal Finance
Banking & Budgeting
Career & Work
College & Education
Family & Home
Insurance
Loans
Real Estate
Retirement
Taxes
How-to Guides
My Portfolios
Sign In to Create/Edit My Portfolios
Free trial of Real-Time Quotes
Tech Ticker
Get Quotes
Finance Search
Opexa Therapeutics, Inc. (OPXA)
On
Dec 24
:
1.98
0.01
(0.50%)
MORE ON OPXA
Quotes
Summary
Real-Time
Options
Historical Prices
Charts
Interactive
Basic Chart
Basic Tech. Analysis
News & Info
Headlines
Financial Blogs
Company Events
Message Board
Company
Profile
Key Statistics
SEC Filings
Competitors
Industry
Components
Analyst Coverage
Analyst Opinion
Analyst Estimates
Research Reports
Star Analysts
Ownership
Major Holders
Insider Transactions
Insider Roster
Financials
Income Statement
Balance Sheet
Cash Flow
Research Reports
Get
Research Reports
for:
RECENT REPORTS
Released
Contributor
Author
Title
Pages
Price
19-Dec-2009
PriceTarget Research, Inc.
N/A
Biotechnology Intelligence Monitor: overall outlook NEUTRAL - 25 new Leaders; 23 new Laggards.
63
$20
18-Dec-2009
Pechala's Reports
Lubomir Pechala
OPEXA THERAPEUTICS INC (OPXA=US) 2-weeks forecast
1
$10
18-Dec-2009
Pechala's Reports
Frantisek Pechala
OPEXA THERAPEUTICS INC (OPXA=US) 12-months forecast
1
$15
8-Dec-2009
EconomicInvestor
N/A
"The Economy Matters" Report for OPXA: the economy's impact on OPXA's price and risk, featuring the powerful EconomicInvestor Star Rating
6
$15
7-Dec-2009
Wall Street Transcript ,The
The Wall St Transcript
MANAGEMENT TURNOVER REPORT - Opexa Therapeutics Inc. (OPXA)
7
$50
3-Dec-2009
Jefferson Research
N/A
Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of OPEXA THERAPEUTICS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.
3
$20
11-Nov-2009
Institutional Shareholder Services
N/A
ISS Report on Opexa Therapeutics, Inc.
11
$135
View All Reports for OPXA ...
Add to Portfolio
Set Alert
Email to a Friend
Get
Research Reports
for Another Symbol:
Symbol Lookup
Upgrades & Downgrades
Conference Calls